ABSTRACT
Despite ongoing containment and vaccination efforts, cholera remains prevalent in many countries in sub-Saharan Africa. Part of the difficulty in containing cholera comes from our lack of understanding of how it circulates throughout the region. To better characterize regional transmission, we generated and analyzed 118 Vibrio cholerae genomes collected between 2007-2019 from five different countries in Southern and Eastern Africa. We showed that V. cholerae sequencing can be successful from a variety of sample types and filled in spatial and temporal gaps in our understanding of circulating lineages, including providing some of the first sequences from the 2018-2019 outbreaks in Uganda, Kenya, Tanzania, Zambia, and Malawi. Our results present a complex picture of cholera transmission in the region, with multiple lineages found to be co-circulating within several countries. We also find evidence that previously identified sporadic cases may be from larger, undersampled outbreaks, highlighting the need for careful examination of sampling biases and underscoring the need for continued and expanded cholera surveillance across the African continent.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was provided by the National Institutes of Health under award number R01HS028634 (A.M.M), K24AI141580 (A.M.M.), and R0AI123422 (A.K.D); Bill and Melinda Gates Foundation INV-047156 (D.S., A.K.D., S.W.); and OPP1195157 (J.L. and S.W.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Samples from Kenya were collected as part of studies approved by the relevant Institutional Review Boards or Ethics Committees at Johns Hopkins Bloomberg School of Public Health (JHSPH; IRB numbers: 00009067, 00008982) and locally (approval number: ESRC P552/2018). Samples in Zambia, Tanzania, and Uganda were collected under JHSPH IRB 00008193, and IRB00008221, respectively, with local approval. Samples analyzed from Malawi were collected under routine public health surveillance. Sequencing and secondary analysis of these samples were determined by JHSPH to be non-human subjects research and exempt from further review.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
